Article Details

AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 bln deal | Financial Post

Retrieved on: 2023-01-09 10:33:23

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 bln deal | Financial Post. View article details on hiswai:

Excerpt

AstraZeneca said on Monday it has struck a deal to buy U.S.-based biopharmaceutical firm CinCor Pharma Inc for up to $1.8 billion to strengthen ...

Article found on: financialpost.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up